Science in Motion.
Canaritech is not a single bet. It is a platform of complementary assets — generating revenue today while building transformational value for tomorrow.
● Scaling
● Early Stage
● Long Term
Revenue Now
Enterprise AI implementation for pharma and biotech companies in LATAM. Governance, agents, and measurable operational impact in 90–120 days.
Scaling
We help biotech startups move from lab to production. Scale-up design, process optimization, and technical advisory — at 30–60% lower cost than U.S. providers.
Scaling
Veterinary biotech platform: qPCR diagnostic kits, recombinant proteins, vaccines, and immunotherapy for swine, bovine, and poultry markets.
Scaling
Contract Research Organization based in Santa Fe, New Mexico. Phase I–IV clinical trials, FDA/COFEPRIS regulatory services, and LATAM patient recruitment.
Early Stage
Topical veterinary solution developed with UNAM researchers to combat screwworm in cattle. Targeting ranchers, veterinarians, and livestock associations across Mexico.
Long Term
Next-generation battery technology. Ionogel improves energy density and lifespan for advanced applications. IP being structured for licensing, JV, or investment.
Long Term
Proprietary vaccine platform targeting PRRS — one of the most economically damaging swine diseases globally. High-margin, scalable, with IPO and licensing potential.
The right time to be part of this is now.
Whether you are an investor, a pharma operator, or a strategic partner — there is a place for you in the Canaritech platform.